Skip to main content
. 2008 Jan 22;98(2):316–322. doi: 10.1038/sj.bjc.6604186

Table 2. Antitumour activity.

  All patientsa (n=45)
History of previous adjuvant chemotherapy
      Yes (n=9)
No (n=36)
Response No. (%) No. (%) No. (%)
CR 2 4.4 1 11.1 1 2.8
PR 20 44.5 2 22.2 18 50.0
SD 15 33.3 6 66.7 9 25.0
PD 6 13.3 0 0 6 16.7
NAb 2 4.4 0 0 2 5.6
a

Intention-to-treat analysis.

b

Not assessable.